Saracatinib in Treating Patients With Metastatic or Locally Advanced Breast Cancer That Cannot Be Removed By Surgery
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Estrogen Receptor-negative Breast Cancer|Male Breast Cancer|Progesterone Receptor-negative Breast Cancer|Recurrent Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer|Stage IV Breast Cancer
Interventions: DRUG: saracatinib|OTHER: laboratory biomarker analysis
Sponsor: National Cancer Institute (NCI)